InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,967.84
(
-0.22%
)
US TECH 100
21,102.40
(
-0.27%
)
Dow Jones
42,206.82
(
0.08%
)
Brent Oil
76.13
(
0.00%
)
Bitcoin
99,322.60
(
-2.82%
)
Post# of 255527
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 121702
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 235816

Monday, 11/23/2020 12:06:52 PM

Monday, November 23, 2020 12:06:52 PM

Post# of 255527
AZN—It seems counterintuitive that the half-sized priming dose produced better efficacy than the full-sized priming dose. However, it’s conceivable that the lower priming dose was genuinely beneficial insofar as it produced fewer neutralizing antibodies against the viral vector used for vaccine delivery, enabling the boost (i.e. second) dose to work with less interference.

Of course, the observed efficacy disparity between AZN’s two dosing regimens could also be a statistical fluke.

More discussion:
https://www.evaluate.com/vantage/articles/news/trial-results/five-questions-astrazeneca-its-covid-19-vaccine

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up